“showed a trend”

Analysis of accuracy revealed marginally significant effects for target presence [present: .91 ± .01, absent: .93 ± .01; F (1, 26) = 3.93, p = .058, ŋ 2 p = .13] and for the interaction between condition and target presence, F (1, 26) = 3.89, p = .059, ŋ 2 p = .13, which showed a trend for higher accuracy for safe versus avoidance conditions in target absent trials.

The squared age term was not significant for both DVs but showed a trend for active sourcing ( OR = 0.999, SE < 0.001, p = 0.058).

Figure 3(b) illustrates that patients with cardiac inflammation showed a trend towards increased numbers of MSC (CD45 − CD34 − CD90 + CD105 + , 0.80 ± 0.67 versus 1.89 ± 1.03/100 mm 2 , P = 0.058) in their EMB compared to patients without inflammation and showed a strong correlation between MSC and cardiac inflammation ( r = 0.64, P = 0.0001, not shown).

In the current study, expression of cathepsin B showed a trend (P=0.058) to independently predict breast cancer disease-free survival; however, this results was not statistically significant.

While participants with 4 trials showed a trend for significance in increased eating frequency ( B = 0.035, SE = 0.018, t = 1.91, P = 0.058), those with 5 or more showed no change (all p s > 0.143) or a decrease (participants with 7 app-uses: B = −0.032, SE = 0.015, t = −2.16, P = 0.032) in eating frequency.

Moreover, AST activity showed a trend towards correlation with NE ( r = 0.468, P = 0.058; Figure 9B ).

However, CD45RA + TCD DLI showed a trend toward improved 1-year COVID-19–free survival ( p = 0.058) and significantly better survival among HSCT recipients ( p = 0.0362).

Antiplatelet therapy was associated with improved functional outcomes at discharge (odds ratio=1.405 [95% CI, 1.028–1.920]; P =0.033), and showed a trend towards reducing 1‐year mortality (odds ratio=0.395 [95% CI, 0.152–1.031]; P =0.058).

Similarly, the corneal total RMS was significantly reduced at the end of the 1-year follow-up compared to the baseline assessment ( p = 0.039), while the reduction in HOAs showed a trend towards statistical significance ( p = 0.058) ( Table 1 ).

Ppargc1a showed a trend (p = 0.058 by Kruskal-Wallis test) to be different between the groups.

We also performed regression analysis for the DAN and VAN in the alpha band, demonstrating that correlation between the VAN and USN index showed a trend for significance (F(1,11) = 4.403, p = 0.058, r 2 = 0.286), while correlation in the DAN did not reach significant level (F(1,11) = 1.442, p = 0.255, r 2 = 0.116) ( Figure 5 ).

In contrast, in late-stage organoids (D150 + 28), mannitol-treated samples showed a trend toward increased BAX expression compared with both control and L-glucose (one-way ANOVA, p = 0.058) and a marked elevation of BIM levels, while PUMA remained unchanged (Fig.

Old‐new effects between 300 and 600 ms The old/new effect for recollection, contrasting ‘recollected’ and ‘familiar’ old faces, showed a trend for a significant race × anterior/posterior interaction, F (1,32) = 3.9, p = .058, η p 2 = 0.11, because amplitudes tended to be more positive for African American than Caucasian faces over anterior, F (1,32) = 5.0, p = .064 (uncorrected .032), η p 2 = 0.14, but not posterior recording sites, p = .60.

The use of antiarrhythmic drugs other than beta-blockers showed a trend (OR 3.18, p = 0.058).

Attempts to solve the task The factor species showed a trend towards affecting the frequency of attempts to solve the task (i.e. getting the food) (GLMM, LRT: χ 2 (1) = 3.35, p = 0.058), with dogs tending to attempt more often than pigs ( Z = −1.891, p = 0.058; figure 4a ; see electronic supplementary material, table S9 for complete model results).

1XMETH significantly reduced density of TH fibers in SNpr (Two-way ANOVA, treatment p<0.001, F (2,48) = 98.444; p<0.001, post hoc Newman-Keuls test; Fig 5A, B ) in both Nurr1 +/+ (n = 10) and +/− (n = 10) mice; Nurr1 +/− mice showed a trend towards greater decrease in THir in SNpr (Two-way ANOVA, p = 0.058, post hoc Newman-Keuls test). 2XMETH caused a further reduction in TH fiber density in SNpr in both Nurr1 +/+ (n = 8) and +/− (n = 7) animals (Two-way ANOVA, p<0.001, post hoc Newman-Keuls test).

In Kaplan–Meier analysis, OS showed a trend toward difference by receipt of any systemic therapy (TKI and/or IO) versus none (log-rank p = 0.058) (Fig. 1 ).

Although not significant, patients comprised in cluster 4 showed a trend towards a less frequency of arthralgia (OR-like: 0.40; 95% CI: 0.15 to 1.03; p=0.058), whereas a higher rate of skin rash (OR-like: 2.06; 95% CI: 1.00 to 4.26; p=0.050).

The proportion of ITGB7 + IgA2 early PBs showed a trend toward reduction ( p = 0.058) ( Figures 4 D and 4E), while the proportion of ITGB1-expressing early PBs trended upward ( p = 0.073) ( Figure 4 D) after belimumab-rituximab combination therapy compared to after rituximab alone (where the proportion of ITGB7 + IgA2 early PBs increased).

The ratio of triglyceride to HDL-cholesterol showed a trend-level difference between CL/OL/QT group and ARP/ZPS group (p=0.058).

However, the IG showed a trend for improvement in the IADL score from baseline to 4 week (5.53 ± 0.68 vs. 6.2 ± 0.53, p = 0.058).

As reported in Table 3 , although a less than acceptable discriminatory power persisted for this miRNAs panel, the combination of the three miRNAs with the CA 19-9 determinations (jointly considered) showed a trend toward a better discriminatory ability (AUC = 0.936; 95%CI: 0.904-0.968) compared to the CA 19-9 test alone ( p = 0.058 from DeLong test).

Patients who contracted COVID-19 showed a trend of lower spike IgG titers in the sampling prior to disease compared to those who remained uninfected (p = 0.058, Fig. 2 F), possibly indicating waning of protective antibody levels resulting in increased susceptibility to infection. 3.4 Generation of spike-specific memory B-cells occurs after vaccination Out of the 17 subjects who were sampled at baseline, all had undetectable spike-specific switched memory B-cells (MBC), except one CKD patient and four controls, who expressed possibly false positive low levels (p < 0.05).

Using the external datasets, we observed consistent associations between LST and female reproductive disorders, including menorrhagia (OR = 1.147, 95% CI: 1.037 to 1.268), endometriosis (OR = 1.197, 95% CI: 1.007 to 1.424), and PCOS (OR = 1.415, 95% CI: 1.085 to 1.845), while ectopic pregnancy showed a trend of elevated risk with 95% CI overlapping with the null (OR = 1.251, 95% CI: 0.992 to 1.578, P = 0.058; see Table S15 and Fig. 6 A).

Lower baseline LVEF ( n = 68) showed a trend towards worse PFS (HR: 0.90, 95% CI: 0.81–1.00, p = 0.058, p adj = 0.14).